See also this year's filing and all EDGAR filings for this company.
PDF Report 0000886163_2020_Ligand_Pharmaceuticals_INC.pdf
Logs
Graph
Absolute values for 0000886163, Ligand Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,123,645,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 305,677,000 |
| 2 | PropertyPlantAndEquipmentNet | 7,185,000 |
| 3 | remainder_Assets | 58,408,000 |
| 4 | LiabilitiesCurrent | 17,002,000 |
| 5 | LiabilitiesNoncurrent | 32,450,000 |
| 6 | remainder_Liabilities | 678,231,000 |
| 7 | CostOfGoodsAndServicesSold | 6,219,258 |
| 8 | SellingGeneralAndAdministrativeExpense | 43,077,295 |
| 9 | ResearchAndDevelopmentExpense | 73,799,356 |
| 10 | remainder_Expenses | 45,901,817 |
| 11 | remainder_Revenues | 159,373,155 |
| 12 | remainder_NetIncome | 4,732,340,333 |
| 13 | remainder_ComprehensiveNetIncome | -18,547 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,494,915,000 |
| 1 | Liabilities | 727,683,000 |
| 2 | Expenses | 168,997,726 |
| 3 | Revenues | 159,373,155 |
| 4 | StockholdersEquity | 767,232,000 |
| 5 | NetIncome | 4,722,715,762 |
| 6 | ComprehensiveNetIncome | 4,722,706,488 |
| 7 | BaseVar | 3,641,663,880 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 5.75 |
| 9 | EconomicCapitalRatio | 5.85 |
Edgar->Model Mapping
Feature Distribution
Change over Time
